ScreenerHero
ZOEZoetis Inc.
XETRA · DE · Technology · Drug Manufacturers - Specialty & Generic · zoetis.com
64.46EUR-1.41%Mkt Cap: 29.37B $P/E: 12.36

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health solutions for the ani…

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all
MRK
MERCK Kommanditgesellschaft auf Aktien
$65.24BUSDP/E 23.7
HLN
Haleon plc American Depositary Shares (Each representing two Ordinary Shares)
$43.41BUSDP/E 20.1
UTHR
United Therapeutics Corporation
$22.70BUSDP/E 19.0
VTRS
Viatris, Inc.
$18.66BUSD
SOBI
Swedish Orphan Biovitrum AB
$15.39BUSDP/E 118.0
NBIX
Neurocrine Biosciences, Inc.
$15.81BUSDP/E 22.8
IPN
Ipsen S.A.
$14.67BUSDP/E 26.5
ELAN
Elanco Animal Health Incorporat
$12.24BUSD
KRK
Krka, d. d.
$8.57BUSDP/E 18.8
HIMS
Hims & Hers Health, Inc.
$7.25BUSD
LQDA
Liquidia Corporation
$6.74BUSDP/E 53.8
LNTH
Lantheus Holdings Inc
$6.56BUSDP/E 24.0
AMRX
Amneal Pharmaceuticals, Inc.
$6.23BUSDP/E 37.3
INDV
Indivior PLC Ordinary Shares
$4.61BUSDP/E 14.0
HIK
Hikma Pharmaceuticals PLC
$4.32BUSDP/E 12.5
AMLX
Amylyx Pharmaceuticals Inc. Common Stock
$4.30BUSD
SFZN
Siegfried Holding AG
$3.91BUSDP/E 20.4
ROVI
Laboratorios Farmaceuticos Rovi, S.A.
$3.34BUSDP/E 16.6
SUPN
Supernus Pharmaceuticals, Inc.
$2.82BUSD
ALM
Almirall, S.A.
$2.46BUSDP/E 37.1

Key Statistics

Company
Market Cap29.37B $
Enterprise Value37.60B $
Revenue (TTM)10.35B $
Gross Profit7.39B $
Net Income (TTM)2.91B $
Revenue/Share24.06 USD
Last Price64.46 EUR
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees14.5K
CountryDE
SectorTechnology
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)12.36
P/E (Forward)—
PEG6.85
EV/EBITDA8.51
EV/Revenue3.63
P/S2.84
P/B9.70
EPS (TTM)5.29
EPS (Forward)—
52W Range
63.0046% of range66.20
52W High66.20 EUR
52W Low63.00 EUR
Profitability
Gross Margin71.84%
Oper. Margin40.72%
EBITDA Margin42.69%
Profit Margin28.23%
ROE80.25%
ROA17.28%
Growth
Revenue Growth-0.20%
Earnings Growth1.20%
Cash Flow & Leverage
Operating CF3.16B $
CapEx (TTM)675.00M $
FCF Margin21.18%
FCF Yield7.47%
Net Debt8.24B $
Net Debt/EBITDA1.86
Balance Sheet
Debt/Equity2.77
Current Ratio3.08
Quick Ratio1.57
Book Value/Sh6.739 EUR
Cash/Share4.056 EUR
Dividends
Fwd Div Rate1.850 EUR
Trail. Div Rate2.060 EUR
Div. Yield2.81%
5Y Avg Yield0.96%
Payout Ratio33.61%
Ex-Div DateJul 20, 2026
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.413.22M
Float412.37M
Insiders0.16%
Institutions100.21%
Technical
SMA 5066.28 (-2.8%)
SMA 20090.40 (-28.7%)
Beta0.73
S&P 52W Chg18.16%
Avg Vol (30d)1.28K
Avg Vol (10d)3.98K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—